Russell G. Dushin
Pfizer (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Multiple Myeloma Research and Treatments, Synthesis and Biological Evaluation, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates(2013)488 cited
- → A general approach to site-specific antibody drug conjugates(2014)312 cited
- → Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design(2016)201 cited
- → Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)(2017)199 cited
- → Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading(2015)166 cited
- → A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions(2017)154 cited
- → Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates(2015)148 cited
- → Kinetically guided radical-based synthesis of C(sp 3 )−C(sp 3 ) linkages on DNA(2018)131 cited
- → Total synthesis of (.+-.)-isolobophytolide and (.+-.)-crassin by titanium-induced carbonyl coupling(1990)103 cited
- → RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models(2016)99 cited